The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 27,799,304 | 908,474 | SH | SOLE | 908,474 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 20,133,537 | 489,153 | SH | SOLE | 489,153 | 0 | 0 | |||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 23,505,242 | 254,827 | SH | SOLE | 254,827 | 0 | 0 | |||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 22,438,840 | 881,337 | SH | SOLE | 881,337 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 9,765,498 | 355,109 | SH | SOLE | 355,109 | 0 | 0 | |||
| REGENXBIO INC | COM | 75901B107 | 14,403,511 | 802,424 | SH | SOLE | 802,424 | 0 | 0 | |||
| REPARE THERAPEUTICS INC | COM | 760273102 | 4,622,878 | 633,271 | SH | SOLE | 633,271 | 0 | 0 | |||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 18,121,843 | 1,043,284 | SH | SOLE | 1,043,284 | 0 | 0 | |||
| S&P BIOTECH ETF TR | UNIT | 78464A870 | 17,858,000 | 200,000 | SH | Put | SOLE | 0 | 0 | 200,000 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 1,804,584 | 420,649 | SH | SOLE | 420,649 | 0 | 0 | |||